1. Home
  2. TRVI vs AIOT Comparison

TRVI vs AIOT Comparison

Compare TRVI & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • AIOT
  • Stock Information
  • Founded
  • TRVI 2011
  • AIOT 1993
  • Country
  • TRVI United States
  • AIOT United States
  • Employees
  • TRVI N/A
  • AIOT N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • TRVI Health Care
  • AIOT Telecommunications
  • Exchange
  • TRVI Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • TRVI 725.7M
  • AIOT 594.8M
  • IPO Year
  • TRVI 2019
  • AIOT N/A
  • Fundamental
  • Price
  • TRVI $6.89
  • AIOT $4.21
  • Analyst Decision
  • TRVI Strong Buy
  • AIOT Strong Buy
  • Analyst Count
  • TRVI 9
  • AIOT 4
  • Target Price
  • TRVI $19.94
  • AIOT $10.50
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • AIOT 2.2M
  • Earning Date
  • TRVI 08-07-2025
  • AIOT 08-07-2025
  • Dividend Yield
  • TRVI N/A
  • AIOT N/A
  • EPS Growth
  • TRVI N/A
  • AIOT N/A
  • EPS
  • TRVI N/A
  • AIOT N/A
  • Revenue
  • TRVI N/A
  • AIOT $362,515,000.00
  • Revenue This Year
  • TRVI N/A
  • AIOT $21.96
  • Revenue Next Year
  • TRVI N/A
  • AIOT $10.74
  • P/E Ratio
  • TRVI N/A
  • AIOT N/A
  • Revenue Growth
  • TRVI N/A
  • AIOT 169.28
  • 52 Week Low
  • TRVI $2.36
  • AIOT $3.70
  • 52 Week High
  • TRVI $7.48
  • AIOT $8.71
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.54
  • AIOT 40.45
  • Support Level
  • TRVI $5.41
  • AIOT $4.18
  • Resistance Level
  • TRVI $6.08
  • AIOT $4.52
  • Average True Range (ATR)
  • TRVI 0.32
  • AIOT 0.19
  • MACD
  • TRVI 0.14
  • AIOT 0.01
  • Stochastic Oscillator
  • TRVI 89.91
  • AIOT 21.65

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: